All tenders
75F40126C00055
BAA FY26C1FP7; MD ANDERSON; ONCOLOGY CENTER FOR EXCELLENCE (OCE), EVALUATING BAYESIAN EFFECTIVE SAMPLE SIZE AND DECISION CRITERIA FOR PEDIATRIC AND RARE DISEASE TRIALS
Food and Drug Administration · United States
This contract has been awarded. Browse open opportunities
Time Left to Bid
Awarded
AwardedOtherFederal
Basic information
- Reference number
- 75F40126C00055
- Issuing organization
- Food and Drug Administration · Find award history →
- Government level
- Federal
- Solicitation type
- Other
- Title
- BAA FY26C1FP7; MD ANDERSON; ONCOLOGY CENTER FOR EXCELLENCE (OCE), EVALUATING BAYESIAN EFFECTIVE SAMPLE SIZE AND DECISION CRITERIA FOR PEDIATRIC AND RARE DISEASE TRIALS
- Source
- USASpending (Federal)
- Source ID
- usa-75F40126C00055
Details
- Location
- United States
Description
BAA FY26C1FP7; MD ANDERSON; ONCOLOGY CENTER FOR EXCELLENCE (OCE), EVALUATING BAYESIAN EFFECTIVE SAMPLE SIZE AND DECISION CRITERIA FOR PEDIATRIC AND RARE DISEASE TRIALS Awarded to: THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER Agency: Department of Health and Human Services Sub-agency: Food and Drug Administration Award type: DEFINITIVE CONTRACT
Dates
- Publication
- 2026/09/30 12:00:00 AM UTC
- Closing date
- 2028/09/29 12:00:00 AM UTC
Estimated value
$752K USD
Classification
Normalized category
Other